COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
4.410
-0.040 (-0.90%)
At close: Nov 22, 2024, 4:00 PM
4.550
+0.140 (3.17%)
After-hours: Nov 22, 2024, 7:58 PM EST
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $301.74 million as of November 22, 2024. Its market cap has decreased by -19.42% in one year.
Market Cap
301.74M
Enterprise Value
127.34M
1-Year Change
-19.42%
Ranking
Category
Stock Price
$4.41
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $301.74M, a decrease of -46.93%. That is a compound annual growth rate of -14.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 318.84M | -41.13% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delcath Systems | 314.94M |
| Cerus | 310.14M |
| Nyxoah | 309.84M |
| Kodiak Sciences | 309.76M |
| ClearPoint Neuro | 305.91M |
| Nautilus Biotechnology | 298.84M |
| Accolade | 298.79M |
| iTeos Therapeutics | 297.02M |